Cargando…
Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
BACKGROUND: Febrile neutropaenia (FN) and resultant infections are the major cause of treatment-related morbidity and mortality in patients receiving chemotherapy. Clinical practice guidelines recommend the use of granulocyte colony-stimulating factors (G-CSF) to reduce the risk of FN and ensuing co...
Autores principales: | Shokane, Lucky L., Bezuidenhout, Selente, Lundie, Maryke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091061/ https://www.ncbi.nlm.nih.gov/pubmed/37064644 http://dx.doi.org/10.4102/hsag.v28i0.2221 |
Ejemplares similares
-
Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
por: Ashrafi, Farzaneh, et al.
Publicado: (2018) -
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
por: Advani, S. H., et al.
Publicado: (2010) -
Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis
por: Katano, Mitsuo, et al.
Publicado: (1995) -
Granulocyte colony-stimulating factor and leukemogenesis.
por: de Figueiredo, Lorena Lobo, et al.
Publicado: (2004) -
Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
por: Gawade, Prasad L., et al.
Publicado: (2020)